Exelixis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.About EXEL
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
As of today, Exelixis(EXEL) shares are valued at $58.10. The company's market cap stands at 14.36B, with a P/E ratio of 17.82.
On 2026-09-25, Exelixis(EXEL) stock traded between a low of $56.06 and a high of $57.99. Shares are currently priced at $58.10, which is +3.6% above the low and +0.2% below the high.
The Exelixis(EXEL)'s current trading volume is 1.89M, compared to an average daily volume of 2.29M.
During the past year, Exelixis(EXEL) stock moved between $33.76 at its lowest and $59.72 at its peak.
During the past year, Exelixis(EXEL) stock moved between $33.76 at its lowest and $59.72 at its peak.
EXEL News
...
Exelixis reported that the FDA extended by three months its review of the zanzalintinib plus atezolizumab NDA for previously treated metastatic colorectal cance...
Analyst ratings
57%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.